Euro-Med Laboratories Phil., Inc. (PSE:EURO)

PSE:EURO Balance Sheet

Financials in millions PHP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,317	1,206	857.62	881.35	615.72	554.5
Trading Asset Securities	312.65	312.65	233.56	202.01	190.6	173.39
Cash & Short-Term Investments	1,630	1,518	1,091	1,083	806.31	727.89
Cash Growth	32.90%	39.15%	0.72%	34.36%	10.77%	-0.62%
Accounts Receivable	2,026	1,841	1,807	1,592	1,439	1,319
Other Receivables	-	113.84	132.2	111.52	43.87	44.07
Receivables	2,026	1,955	1,940	1,703	1,483	1,363
Inventory	1,560	1,582	1,742	1,693	1,537	1,264
Prepaid Expenses	297.5	317.8	330.91	321.84	317.88	296.64
Other Current Assets	57.68	249.44	214.64	334.27	283.44	259.4
Total Current Assets	5,571	5,623	5,318	5,135	4,428	3,911
Property, Plant & Equipment	4,731	4,847	4,933	4,961	4,961	5,052
Long-Term Investments	0.2	0.2	0.2	0.2	0.2	0.2
Other Intangible Assets	270.13	270.13	268.13	268.13	268.13	268.21
Long-Term Deferred Tax Assets	118.62	115.32	122.26	109.15	97.15	105.95
Long-Term Deferred Charges	18.04	12.65	12.65	21.07	38.79	51.44
Other Long-Term Assets	334.05	276.71	295.41	268.76	266.17	302.82
Total Assets	11,043	11,145	10,950	10,764	10,059	9,691

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	353.87	316.7	349.49	477.38	345.59	301.14
Accrued Expenses	74.67	113.64	139.51	104.6	69.31	85.39
Short-Term Debt	2,788	2,998	3,040	3,014	2,633	2,283
Current Portion of Long-Term Debt	202.97	294.91	285.65	209.75	184.3	195.08
Current Portion of Leases	89.35	56.55	66.98	58.6	60.82	49.18
Current Income Taxes Payable	33.55	50.02	26.61	51.64	31.18	22.8
Current Unearned Revenue	9.7	2.12	0.37	1.81	0.75	0.4
Other Current Liabilities	-0	0.42	0.22	0.11	0.62	0.6
Total Current Liabilities	3,552	3,833	3,909	3,918	3,326	2,937
Long-Term Debt	877.62	857.3	774.25	666.91	663.62	788.75
Long-Term Leases	60.31	105.38	125.53	89.48	138.91	105.29
Pension & Post-Retirement Benefits	282.22	281.15	257.96	244.24	221.62	219.32
Total Liabilities	4,773	5,076	5,067	4,919	4,350	4,051

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4,112	4,112	4,112	4,112	4,112	4,112
Additional Paid-In Capital	66.61	66.61	66.61	66.61	66.61	66.61
Retained Earnings	2,109	1,906	1,724	1,692	1,547	1,494
Comprehensive Income & Other	-16.75	-16.75	-19.77	-25.15	-16.52	-31.79
Shareholders' Equity	6,271	6,068	5,883	5,845	5,709	5,641
Total Liabilities & Equity	11,043	11,145	10,950	10,764	10,059	9,691

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4,018	4,312	4,293	4,039	3,681	3,421
Net Cash (Debt)	-2,388	-2,794	-3,202	-2,956	-2,874	-2,693
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.58	-0.68	-0.78	-0.72	-0.70	-0.65
Filing Date Shares Outstanding	4,112	4,112	4,112	4,112	4,112	4,112
Total Common Shares Outstanding	4,112	4,112	4,112	4,112	4,112	4,112
Working Capital	2,018	1,790	1,409	1,217	1,102	973.51
Book Value Per Share	1.52	1.48	1.43	1.42	1.39	1.37
Tangible Book Value	6,000	5,798	5,615	5,577	5,441	5,372
Tangible Book Value Per Share	1.46	1.41	1.37	1.36	1.32	1.31
Land	166.77	166.77	166.77	173.34	131.83	106.59
Buildings	3,174	3,153	3,043	2,981	2,816	2,777
Machinery	6,667	6,657	6,499	6,365	6,278	6,254

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error